Skip to main content

Table 3 Clinical characteristics of CML patients

From: Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding

Parameters

CML (n = 140)

Gender

 

 Male

76 (54%)

 Female

64 (46%)

Mean age (years, range)

51.5 (16-83)

Cytogenetics

 

 t(9;22) only

122 (87.1%)

 trisomy 8

3 (2.1%)

 del Y

5 (3.6%)

 complex karyotype

5 (3.6%)

 other abnormalities

4 (2.9%)

 unknown

1 (0.7%)